Atlas Trials

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Clinical trial NCT03290820 · UNKNOWN

Trial details

NCT number
NCT03290820
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2018-01-01
Primary completion
2024-09-30
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.